Form D · Other Health Care

VERACYTE, INC.

South San Francisco, CA · CIK 0001384101

Offering snapshot reported Sep 30, 2014 · SEC filing

Reported sold
$12.8M
Offering amount: $12.8M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 16, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 30, 2014Initial$12,797,283No comparison6SEC filing
Jun 18, 2010Initial$9,311,668No comparison9SEC filing
Dec 6, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-225555

Source: Form D, filed Sep 30, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bonnie H. Anderson Director, Executive
Brian G. Atwood Director
Julie Brooks Executive
Brook H. Byers Director
Fred E. Cohen Director
Samuel D. Colella Director
Doug Dolginow Director
Karin Eastham Director
Shelly D. Guyer Executive
Evan Jones Director
Jonathan T. Lord Director
Jesse I. Treu Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
7000 Shoreline Court, Suite 250
South San Francisco, CA, 94080